vs
Side-by-side financial comparison of NWPX Infrastructure, Inc. (NWPX) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
NWPX Infrastructure, Inc. is the larger business by last-quarter revenue ($138.3M vs $70.6M, roughly 2.0× Viridian Therapeutics, Inc.\DE). NWPX Infrastructure, Inc. runs the higher net margin — 7.6% vs -49.0%, a 56.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 19.1%).
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
NWPX vs VRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.3M | $70.6M |
| Net Profit | $10.5M | $-34.6M |
| Gross Margin | 19.3% | — |
| Operating Margin | 9.2% | -56.7% |
| Net Margin | 7.6% | -49.0% |
| Revenue YoY | 19.1% | 81958.1% |
| Net Profit YoY | 165.7% | 54.9% |
| EPS (diluted) | $1.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $138.3M | — | ||
| Q4 25 | $125.6M | — | ||
| Q3 25 | $151.1M | $70.6M | ||
| Q2 25 | $133.2M | — | ||
| Q1 25 | $116.1M | — | ||
| Q4 24 | $119.6M | — | ||
| Q3 24 | $130.2M | — | ||
| Q2 24 | $129.5M | — |
| Q1 26 | $10.5M | — | ||
| Q4 25 | $8.9M | — | ||
| Q3 25 | $13.5M | $-34.6M | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $4.0M | — | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $10.3M | — | ||
| Q2 24 | $8.6M | — |
| Q1 26 | 19.3% | — | ||
| Q4 25 | 21.3% | — | ||
| Q3 25 | 21.3% | — | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 16.7% | — | ||
| Q4 24 | 18.8% | — | ||
| Q3 24 | 20.8% | — | ||
| Q2 24 | 19.9% | — |
| Q1 26 | 9.2% | — | ||
| Q4 25 | 10.4% | — | ||
| Q3 25 | 12.6% | -56.7% | ||
| Q2 25 | 9.9% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 8.8% | — | ||
| Q3 24 | 11.9% | — | ||
| Q2 24 | 10.5% | — |
| Q1 26 | 7.6% | — | ||
| Q4 25 | 7.1% | — | ||
| Q3 25 | 8.9% | -49.0% | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 3.4% | — | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 6.7% | — |
| Q1 26 | $1.08 | — | ||
| Q4 25 | $0.88 | — | ||
| Q3 25 | $1.38 | — | ||
| Q2 25 | $0.91 | — | ||
| Q1 25 | $0.39 | — | ||
| Q4 24 | $1.00 | — | ||
| Q3 24 | $1.02 | — | ||
| Q2 24 | $0.86 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.3M | $490.9M |
| Total DebtLower is stronger | $10.7M | — |
| Stockholders' EquityBook value | $403.7M | $503.0M |
| Total Assets | $634.1M | $577.1M |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $14.3M | — | ||
| Q4 25 | $2.3M | — | ||
| Q3 25 | $2.7M | $490.9M | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $5.0M | — | ||
| Q3 24 | $5.7M | — | ||
| Q2 24 | $4.5M | — |
| Q1 26 | $10.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $403.7M | — | ||
| Q4 25 | $394.8M | — | ||
| Q3 25 | $386.4M | $503.0M | ||
| Q2 25 | $379.5M | — | ||
| Q1 25 | $378.5M | — | ||
| Q4 24 | $374.0M | — | ||
| Q3 24 | $362.4M | — | ||
| Q2 24 | $351.2M | — |
| Q1 26 | $634.1M | — | ||
| Q4 25 | $579.6M | — | ||
| Q3 25 | $605.2M | $577.1M | ||
| Q2 25 | $592.6M | — | ||
| Q1 25 | $582.2M | — | ||
| Q4 24 | $589.7M | — | ||
| Q3 24 | $617.2M | — | ||
| Q2 24 | $631.7M | — |
| Q1 26 | 0.03× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.3M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 2.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $29.3M | — | ||
| Q4 25 | $36.0M | — | ||
| Q3 25 | $21.0M | $-84.6M | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $4.8M | — | ||
| Q4 24 | $36.1M | — | ||
| Q3 24 | $22.7M | — | ||
| Q2 24 | $22.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $30.8M | — | ||
| Q3 25 | $13.2M | $-84.7M | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $31.9M | — | ||
| Q3 24 | $16.8M | — | ||
| Q2 24 | $16.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 24.5% | — | ||
| Q3 25 | 8.7% | -120.1% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 26.7% | — | ||
| Q3 24 | 12.9% | — | ||
| Q2 24 | 12.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | — | ||
| Q3 25 | 5.2% | 0.2% | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 4.7% | — |
| Q1 26 | 2.78× | — | ||
| Q4 25 | 4.06× | — | ||
| Q3 25 | 1.55× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.22× | — | ||
| Q2 24 | 2.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NWPX
| Water Transmission Systems | $93.5M | 68% |
| Precast Infrastructure and Engineered Systems | $44.8M | 32% |
VRDN
Segment breakdown not available.
